NewslettersHuman Immunology News Sandoz Confirms European Commission Approval of Pyzchiva® (Ustekinumab), Further Strengthening Immunology Offering By Jamie Kang - April 23, 2024 0 Sandoz announces that the European Commission has granted marketing authorization for Pyzchiva® (biosimilar ustekinumab), developed and registered by Samsung Bioepis. [Sandoz] Press Release